Native Size-Exclusion Chromatography-Mass Spectrometry: Suitability for Antibody–drug Conjugate Drug-To-Antibody Ratio Quantitation Across a Range of Chemotypes and Drug-Loading Levels

mAbs - United States
doi 10.1080/19420862.2019.1682895
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Native Quantitative Determination of Antibody-Drug Conjugate Affinity and Stability

Biophysical Journal
Biophysics
2019English

Studies on Antibody-Anticancer Drug Conjugate

Okayama Igakkai Zasshi (Journal of Okayama Medical Association)
1984English

Tumor Stroma–targeted Antibody-Drug Conjugate Triggers Localized Anticancer Drug Release

Journal of Clinical Investigation
Medicine
2018English

Antibody–Drug Conjugate Hits Elusive HER2 + Breast Tumors

Cancer Discovery
Oncology
2013English

Impact of Linker-Drug on Ion Exchange Chromatography Separation of Antibody-Drug Conjugates

mAbs
AllergyImmunology
2019English

Design and Characterization of Homogenous Antibody-Drug Conjugates With a Drug-To-Antibody Ratio of One Prepared Using an Engineered Antibody and a Dual-Maleimide Pyrrolobenzodiazepine Dimer

mAbs
AllergyImmunology
2019English

Intracellular Catabolism of an Antibody Drug Conjugate With a Noncleavable Linker

Drug Metabolism and Disposition
PharmacologyPharmaceutical Science
2015English

Antibody – Drug Conjugates (ADC) – Drug Discovery Today: Technologies

Drug Discovery Today: Technologies
BiotechnologyDrug DiscoveryMolecular Medicine
2018English

LGR5-Targeted Antibody-Drug Conjugate Eradicates Gastrointestinal Tumors and Prevents Recurrence

Molecular Cancer Therapeutics
Cancer ResearchOncology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy